Article
Cardiac gene therapy with adeno-associated virus-based vectors
16 Feb 2017
Abstract excerpt
PURPOSE OF REVIEW: Cardiac gene therapy with adeno-associated virus (AAV)-based vectors is emerging as an entirely new platform to treat, or even cure, so far intractable cardiac disorders. This review describes our current knowledge of cardiac AAV gene therapy with a particular focus on the biggest obstacle for the successful translation of cardiac AAV gene therapy into the clinic, namely the efficient delivery...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
